Treatment

Displaying 11 - 20 of 248

Pericardial aortic surgical valve approved in U.S. and Europe

Pericardial aortic surgical valve approved in U.S. and Europe
Medtronic plc has announced CE mark and U.S. FDA approval of its new Avalus pericardial aortic surgical valve for the treatment of aortic valve disease. The Avalus valve leverages proven surgical bioprosthetic valve concepts with added features designed to enhance clinical performance, helping to address the contemporary needs of cardiac surgeons, as well as patients who are candidates for aortic valve replacement.
3rd August 2017

Dialysis armchairs turn into e-health tech vectors

Dialysis armchairs turn into e-health tech vectors
ANDRA Dialysis center (in Buttes Chaumont, Paris) is starting its first steps towards e-health buying B. Braun new armchairs combined with Htab solution (from ARBOR and Tmm software). In the 19th district of Paris, ANDRA's 18 new armchairs arouse curiosity. Each one is equipped with 10" touch-screen terminal to liven up patients' 4 hours of dialysis, which is especially uncomfortable for patients suffering from kidney failure.
3rd August 2017

CoreValve Evolut PRO receives CE Mark and European launch

CoreValve Evolut PRO receives CE Mark and European launch
Medtronic plc has announced CE mark and European launch of the CoreValve Evolut PRO valve for the treatment of severe aortic stenosis for symptomatic patients who are at intermediate, high or extreme risk for open heart surgery. Clinical data for the Evolut PRO valve was recently unveiled at the American College of Cardiology (ACC) 66th Annual Scientific Session, and showed high survival, low rates of stroke, minimal paravalvular leak (PVL) and excellent hemodynamics.
1st August 2017


Stem cell therapy targets cancerous tissue stiffness

Stem cell therapy targets cancerous tissue stiffness
A stem cell-based method created by University of California, Irvine scientists can selectively target and kill cancerous tissue while preventing some of the toxic side effects of chemotherapy by treating the disease in a more localised way. Weian Zhao, associate professor of pharmaceutical sciences, and colleagues have programmed human bone marrow stem cells to identify the unique physical properties of cancerous tissue.
28th July 2017

Stellarex drug-coated balloon receives FDA Approval

Stellarex drug-coated balloon receives FDA Approval
The Spectranetics has announced receipt of U.S. Food and Drug Administration (FDA) Pre-Market Approval (PMA) of the Stellarex drug-coated balloon (DCB), designed to restore and maintain blood flow to the superficial femoral and popliteal arteries in patients with peripheral arterial disease (PAD). “The Stellarex DCB has shown safety and efficacy in a cohort of patients which included a higher preponderance of diabetics and core-lab defined severely calcified lesions in the US IDE trial".
27th July 2017

Immune cells point to new bladder cancer treatment

  Research offers a possible explanation for why a new type of cancer treatment hasn't been working as expected against bladder cancer. The study finds that checkpoint immunotherapy, which is designed to activate the immune system, is not effective on some bladder cancers because there are no immune cells in the tumours.
24th July 2017

Determining when and how to treat heart attacks

Determining when and how to treat heart attacks
Anthony McDougal, a graduate student in MIT’s Department of Mechanical Engineering, has developed a model that predicts a single heart cell’s response to dwindling supplies of oxygen. Specifically, it evaluates a cell’s ability to keep producing ATP — a cell’s primary fuel source — and stay alive, even as it is increasingly deprived of oxygen.
21st July 2017

Non-invasive gammaCore device released in U.S.

Non-invasive gammaCore device released in U.S.
electroCore has announced the commercial launch of gammaCore (non-invasive vagus nerve stimulator) for the acute treatment of pain associated with episodic cluster headache in adult patients in the United States (U.S.). gammaCore is the first non-invasive, hand-held medical device applied at the neck and sends gentle, patented electrical stimulation through the skin to activate the vagus nerve, resulting in the reduction of pain.
21st July 2017

MultiGen 2 RF generator receives FDA Clearance

MultiGen 2 RF generator receives FDA Clearance
Stryker has announced that it has received FDA 510(k) clearance for its MultiGen 2 RF Generator. This product provides physicians with the efficiency, control and reliability they need when performing radiofrequency ablation, a minimally invasive procedure that can provide lasting relief to those suffering from facet joint pain. The MultiGen 2 RF Generator will debut at the Spine Intervention Society's 25th annual meeting, July 19-22, in San Francisco.
21st July 2017

Dolphins inspire trauma treatment

Dolphins inspire trauma treatment
A physiological process used commonly by mammals like seals and dolphins inspired the potentially life-saving method University at Buffalo researchers successfully tested to raise blood pressure in a simulation of trauma victims experiencing blood loss. The pre-hospital intervention is simple—place a bag of ice on the victim's forehead, eyes and cheeks. In a small study, this method was shown to increase and maintain a person's blood pressure during simulated blood loss.
18th July 2017


Treatment documents


Sign up to view our publications

Sign up

Sign up to view our downloads

Sign up

SPE Offshore Europe 2017
5th September 2017
United Kingdom Aberdeen Exhibition & Conference Centre
EPE 2017 ECCE Europe
11th September 2017
Poland Warsaw
ON Semiconductor Power Seminars 2017
11th September 2017
United Kingdom
DSEI 2017
12th September 2017
United Kingdom ExCeL, London
RWM 2017
12th September 2017
United Kingdom NEC, Birmingham